<< Back to News
LifeNet Health and Children's Mercy Hospital Announce First Implant With MatrACELL(TM) Technology

LifeNet Health, a leading allograft bio-implant company, announces the first implant of a CardioGraft(TM) allograft cardiac patch product with MatrACELL(TM)( )decellularization technology. The surgery was performed at Children's Mercy Hospital in Kansas City, Mo by Gary K. Lofland, MD, FACS, Section Chief, Cardiovascular Surgery at Children's Mercy Hospital in Kansas City, Mo, The Joseph Boon Gregg/Missouri Endowed Chair in Pediatric Cardiac Surgery, Professor of Surgery, UMKC.

 
Copyright © 2014 LifeNet Health. All rights reserved.  |  Outside Research Policy Web Development by Web Teks, Inc.